Exchange Traded Concepts’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Exchange Traded Concepts’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-461	Closed	-$146K	–	1471
2023 Q4	$146K	Buy	461 +9	+2%	+$1.75K	﹤0.01%	837
2023 Q3	$76.4K	Buy	452 +116	+35%	+$21.8K	﹤0.01%	966
2023 Q2	$72.9K	Sell	336 -6	-2%	-$1.28K	﹤0.01%	994
2023 Q1	$62.1K	Buy	+342	New	+$65.4K	﹤0.01%	857
2022 Q1	–	Sell	-241	Closed	-$32K	–	1407
2021 Q4	$32K	Buy	241 +75	+45%	+$9.69K	﹤0.01%	975
2021 Q3	$20K	Buy	166 +46	+38%	+$5.31K	﹤0.01%	946
2021 Q2	$14K	Buy	+120	New	+$14K	﹤0.01%	1014

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Exchange Traded Concepts's KRTX Position: Q1 2024 in Review

Exchange Traded Concepts sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 461 shares — an estimated $146K sold.

Exchange Traded Concepts first reported a position in KRTX in Q2 2021 and held it in 7 quarters. The position peaked at $146K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Exchange Traded Concepts reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Exchange Traded Concepts sold 461 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $146K.
Exchange Traded Concepts first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Exchange Traded Concepts's Karuna Therapeutics, Inc. Common Stock position peaked at $146K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Exchange Traded Concepts's 13F filing for Q1 2024, filed 15 Apr 2024.